EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534

Rodrigo L P Romao, Jennifer H Aldrink iD, Lindsay A Renfro, Elizabeth A Mullen, Andrew J Murphy iD, Jack Brzezinski iD, Marcus M Malek iD, Daniel J Benedetti iD, Nicholas G Cost, Ethan Smith, Jeffrey S Dome iD, Andrew M Davidoff und 9 weitere

Pediatric Blood & Cancer · 2024-07 · 71 (7)

DOI: 10.1002/pbc.30981 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 18.04.2024. Verfasst von Rodrigo L P Romao und 20 weiteren Autor:innen. Beteiligte Einrichtung: Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Wilms Tumor, Kidney Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, St. Baldrick's Foundation, NCTN Statistics & Data Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The purpose of this study is to examine the outcomes in children with anaplastic bilateral Wilms tumor (BWT) from study AREN0534 in order to define potential prognostic factors and areas to target in future clinical trials.

Methods

Demographic and clinical data from AREN0534 study patients with anaplasia (focal anaplasia [FA], or diffuse anaplasia [DA]) were compared. Event‐free survival (EFS) and overall survival (OS) were reported using Kaplan–Meier estimation with 95% confidence bands, and differences in outcomes between FA and DA compared using log‐rank tests. The impact of margin status was analyzed.

Results

Twenty‐seven children who enrolled on AREN0534 had evidence of anaplasia (17 DA, 10 FA) in at least one kidney and were included in this analysis. Twenty‐six (96%) had BWT. Nineteen percent had anaplastic histology in both kidneys (four of 17 DA, and one of 10 FA). Forty‐six percent with BWT had bilateral nephron‐sparing surgery (NSS); one child who went off protocol therapy, eventually required bilateral completion nephrectomies. Median follow‐up for EFS and OS was 8.6 and 8.7 years from enrollment. Four‐ and 8‐year EFS was 53% [95% confidence interval (CI): 34%–83%] for DA; 4‐year EFS was 80% [95% CI: 59%–100%], and 8‐year EFS 70% [95% CI: 47%–100%] for FA. Three out of 10 children with FA and eight out of 17 children with DA had events. EFS did not differ statistically by margin status ( p = .79; HR = 0.88). Among the six children who died (five DA, one FA), all experienced prior relapse or progression within 18 months.

Conclusion

Events in children with DA/FA in the setting of BWT occurred early. Caution should be taken about interpreting the impact of margin status outcomes in the context of contemporary multimodal therapy. Future targeted investigations in children with BWT and DA/FA are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wilms TumorKidney NeoplasmsHumansMaleFemaleChild, PreschoolInfantAnaplasiaChildPrognosisSurvival RateFollow-Up StudiesNephrectomy

Stichwörter der Autor:innen

Wilms tumoranaplasiabilateral

Autor:innen und Institutionen

  • Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Nationwide Children's Hospital, The Ohio State University, Columbus, Ohio, USA.
  • Division of Biostatistics, University of Southern California and Children's Oncology Group, Los Angeles, California, USA.
  • Boston Children's Hospital and Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • St Jude's Children's Research Hospital, Memphis, Tennessee, USA.
  • Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Jennifer H Aldrink, Andrew J Murphy, Jack Brzezinski, Marcus M Malek, Daniel J Benedetti, Jeffrey S Dome, Arnold Paulino, James I Geller, Peter F Ehrlich

Förderung

  • NCI NIH HHS
  • St. Baldrick's Foundation
  • NCTN Statistics & Data Center
  • NCTN Operations Center

Zitieren

APA

Romao, R. L. P., Aldrink, J. H., Renfro, L. A., Mullen, E. A., Murphy, A. J., Brzezinski, J., Malek, M. M., Benedetti, D. J., Cost, N. G., Smith, E., Dome, J. S., Davidoff, A. M., Treece, A., Parsons, L. N., Fernandez, C. V., Tornwall, B., Shamberger, R. C., Paulino, A., Kalapurakal, J. A., …, & Ehrlich, P. F. (2024). Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534. Pediatric Blood & Cancer, 71(7). https://doi.org/10.1002/pbc.30981

Vancouver

Romao RLP, Aldrink JH, Renfro LA, Mullen EA, Murphy AJ, Brzezinski J, et al. Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534. Pediatric Blood & Cancer. 2024;71(7). doi:10.1002/pbc.30981

BibTeX
@article{Romao2024,
  author = {Romao, Rodrigo L P and Aldrink, Jennifer H and Renfro, Lindsay A and Mullen, Elizabeth A and Murphy, Andrew J and Brzezinski, Jack and Malek, Marcus M and Benedetti, Daniel J and Cost, Nicholas G and Smith, Ethan and Dome, Jeffrey S and Davidoff, Andrew M and Treece, Amy and Parsons, Lauren N and Fernandez, Conrad V and Tornwall, Brett and Shamberger, Robert C and Paulino, Arnold and Kalapurakal, John A and Geller, James I and Ehrlich, Peter F},
  title = {Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  volume = {71},
  number = {7},
  doi = {10.1002/pbc.30981}
}
Kostenlos starten →